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Objectives. This study was
performed
to assess by echocardi-
ography the intermediate-term outcome of cryopreserved ho-
rnogr4s employed in pulmonary
outflow
raoQeoaastruction in chil-
dren and to validate the reliability of Doppler echocardiography in
their evaluation.
Background. Cryopreserved homograatls have become the most
widely used ptdmtnaary conduits . Previous reports have shown the
cmi'ence of hoana raft regurgitation in the immediate postopera-
dve period and the propensity of regurgitation to pr ress . Although
Doppler echocardiography has been useful in assessing extracardiac
valved conduit stenosis, its reliability ha assessing a large series of
cryop rved hone alts has not been documented .
Methods. Echocardiograms of 41 patients (43 homografts) who
underwent operations between December 1986 and October 1992
were retrospectively reviewed . The median age of patients at
operation was 37.5 months (range 3 to 333), and the median
duration of follow-up was 28 .5 months (range 1 to 68) . Homograft
regurgitation was classified on a scale of 0 to 4+ . Pressure
gradients across the homografts measured in 23 catheterizations
were correlated with corresponding echocardiographic gradients.
Results. Regurgitation: ilotnograft regurgitation occurred in
100% of patients at follow-up Progression of severity >2 grades
Cryopreserved homografts have become the most widely
used pulmonary conduits in pulmonary outflow reconstruc-
tion in children . In a short-term follow-up report from
Meliones et al . (I), --65% of homografts showed regurgita-
tion in the immediate postoperative period and 29% showed
progression of regurgitation during a mean follow-up period
of 15 months. This early development and progression of
pulmonary regurgitation has important implications for the
long-term performance of these cryopreserved homografts .
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occurred during follow-up in 35% and was associat with operation
before age 18 months (p < 0,11 , 2) and sten is progression (p < 0.05)
but not with homograft type (aortic or pulmonary) . These data
predict that 50% of patients operated on before 18 mouths of age will
have severe regurgitation by 15 months postoperatively compared
with only 15% operated on after 18 months . Stenosis: At follow-up,
5118 of lhomogralts had a steatAtic g sdia.-tt - 2S a uta leg praals~ at_a ,
uantly at tile distal anastonttGis, and stew is progression was related
to young age at operation (<I& months, p < 0.005) and small conduit
size (p < 0.01) . Fifty percent of conduits implaar fore age 18
months could be predicted to stenose by 21 .8 months compared with
only 5% of those implanted after age 18 months . The u adient
measured from Doppler echocardiography correlated well with the
catheteriztion gradient (r = 0 .86) .
Conclusions. Cryopreserv boanograft dysfunction is frequent
and progressive. Young age at operation (<18 months) predicts
more rapid deterioration . Doppler
echocardiography
is reliable in
assessing the systolic gradients across homografts . Serial echocar-
diographic assessment in the follow-up of these patients accurately
characterizes these problems .
(J Am Coll Cordial 1994 ;24:483 .-9)
n1
Although Doppler echocardiography has been shown to
be useful in assessing extracardiac valved conduit stenosis
(2), the clinical utility and reliability of Doppler echocardi-
ography in the long-term serial assessment of a large series
of cryopreserved homografts has not been documented .
The purpose of the present study was 1) to serially assess
the systolic and diastolic flow characteristics of cryopre-
served homografts used in ventricular to pulmonary outflow
reconstruction, utilizing echocardiographic examinations in
the early and intermediate term follow-up, and 2) to correlate
the flow characteristics of Doppler echocardiography and
hemodynamic studies in those patients who had cardiac
catheterization .
Methods
Patients studied . Since December 1986, we have exclu-
sively utilized cryopreserved valved homografts (Cryolife,
0735-10971907 .00
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Table 1. Patient Characteristics and Status of Homografts at Last Follow-Up
Inc.) for pulmonary outflow reconstruction at the South
Carolina Children's Heart Center. Records of patients oper-
ated on from December 1136 tc October 1992 and who had
follow-up echocardiograms after the 1st month postopera-
tively were reviewed . All operations were performed by two
surgeons (R.M.S., F.A.C .) . The available echocardiographic
and catheterization data of these patients were retrospec-
tively reviewed and assessed independently of other clinical
data by two observers (K.C.C., D.A.F.) .
Two-dimensional echocardiographic examination . Pa-
tients were examined by two-dimensional, color flow and
continuous wave Doppler echocardiography during the im-
mediate postoperative period and at follow-up .
Doppler echocardiographic examination . Homografts
were visualized and any stenotic sites were located by the
two-dimensional imaging, color flow Doppler and pulsed
Doppler studies. The velocity profiles of the homografts
were quantitated from continuous wave Doppler studies .
The highest peak flow velocities from pulmonary ventricles
across the homografts to the distal pulmonary arteries were
obtained by using a simplified Bernoulli equation : Gradient
across the homograft (mm Hg) = Peak velocity (,nls) 2 x 4 .
Interpretation and definiden of echocardlographic find-
hq;L Stemosis . A homograft was considered mildly stenotic
if the Doppler gradient was 25 to 50 mm Hg and moderately
stenotic if the gradient was >50 mm Hg .
Regurgitation. The severity of pulmonary homograft re-
gurgitation was graded semiquantitatively by measuring the
jet width in a manner analogous to that described for aortic
regurgitation (3) : 0 = absent ; I+ = a pinhole-like jet-very
mild regurgitation ; 2 + = a jet of approximately 20% of the
homograft valve annular width-mild regurgitation
; 3+ = a
jet of approximately 40M% of the annular width and with color
flow reversal above and below the leaflets-moderate regur-
gitation ; and 4+ = a broad-based jet of >40
11o of the annular
width and with color flow reversal in the entire pulmonary
artery-severe regurgitation .
Progression of stenosis and regurgitation . Progression
of
the
homograft
stenosis or regurgitation was quantitated as
the difference between either the stenotic gradient or the
regurgitation grade measured between the first and the last
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echocardiographic study (or the latest cchocardiographic
finding preceding any interventional procedure or opera-
tion). Progression of slenosis was classified as moderate if
the difference between two studies was >20 mm Hg and
severe if the stenosis progression was >40 mm [IS. Progres-
sion of regurgitation 2:2 grades was considered significant .
Cardiac catheterization . Indications for postoperative
cardiac catheterization depended on the clinical suspicion or
echocardiographic demonstration of homograft malfunction .
The homograft gradient measured at cardiac catheterization
was the difference between peak systolic pressure in the
distal pulmonary arteries and the pulmonary ventricle during
catheter pullback, using fluid-filled catheters, before any
angiogram was taken. Only data from patients who had a
corresponding echocardiogram within 24 h of cardiac cath-
eterization were used for correlation .
Statistical analysis. Clinical variables that could affect the
stenotic gradient (diagnosis . age at operation) and the ho-
mograft regurgitation status (diagnosis, concomitant steno-
sis, homograft leaflet abnormalities) at the last follow-up
visit or the progression of stenosis (diagnosis, age at opera-
tion, homograft type) and the progression of regurgitation
(diagnosis, age at operation, stenosis, concomitant stenosis
progression, leaflet abnormalities) during the follow-up pe-
riod were studied ; the Pearson chi-square test or Fisher
exact test, if required, was used for any correlation. A proba-
bility value <0 .05 was considered statistically significant . Cor-
relation between Doppler- and catheterization-obtained gradi-
ents was analyzed by linear regression analysis using the
method of least squares .
Survival analysis. The probability of obtaining progres-
sion of stenosis >20 mm Hg or regurgitation of 3+ or 4+ for
two age groups of patients (<18 months, ?l8 months) was
estimated using the actuarial life table computation of the
survivor func6on .
Results
Clinical characteristics of patients (Table 1) . A total of
forty-one patients (26 male, 15 female) were included . One
patient with tetralogy of Fallot and one patient with truncus
Diagnosis
No. of Patients
(no. of homografts)
No. of Homografts With
Stenosis >25 Anna Hg at
Last Follow-Up
No, of Homografts With
3+ or 4+ Regurgitation
at Last Follow-Up
Tetralogy of Fallot 13(14) II 3
Trunc us arteriosus 10(11) 6 7
D-tmnsposidon, pulmonary stenosis 5(5) 3 1
L-transposition, ventricular inversion, pulmonary stenosis 5(5) 1 2
Pulmonary atresia, ventricular septa[ defect 3(3) 0 0
Pulmonary atresia, intact ventricular septum 2(2) 1 1
infective CrAocadtis 2(2) 0
Critical pulmonary Stenosis 1 (1) 0
Total 410311 22
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Table 2 . Characteristics of Patients With Hompgraft Leaflet Abnormalities
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LWA = f, transposition of gre=at averin ; PA - pulmonary mw1w pustop = postoperative
; PS = pulmonary stenosis ;ToF -- tetralogy of Fallot ; VSD
ventricular septal defect,
arteriosus underwent reoperation to replace a malfunction-
ing homograft . The functional course of all 43 homografts
was then reviewed . The cardiac malformations requiring
homograft use in the 41 patients are shown in Table 1 .
Patient age at the time of operation was 3 to 333 months
(median 37.5). The donor homograft types were aortic (n =
21) and pulmonary (n = 22) ; homograft diameter ranged from
12 to 26 mm . Patients were studied echocardiographically
from I to 68 months (median 28 .5) postoperatively. Four
homografts were followed up to the time of balloon dilation
procedures and two up to surgical replacement . The age of
patients at last echocardiographic examination ranged from 8
to 334 months (median 73). A total of 221 echocardiographic
studies were reviewed .
Conduit Regurgitation
Regurgitation . Homograft regurgitation was present in all
43 homografts (100%) at the last follow-up . Fifteen (35%) of
the 43 homografts had moderate or severe regurgitation . The
presence of regurgitation at follow-up was inversely related
to the size of conduit implanted (p < 0 .01). The occurrence
of moderate or severe regurgitation was not related to the
presence of stenosis >25 mm Hg as measured by Doppler
gradient (7 of 17 vs. 15 of 26, p > 0 .05). Homografts of
patients with truncus arteriosus had a greater frequency of
moderate or severe regurgitation than did those of the other
patients (7 of I I vs . 8 of 32, p !5 0.04).
Regurgitation progression . Progression of the severity of
regurgitation was observed in 74% (32 of 43) of homografts .
Fifteen homografts (35%) had progression >2 grades during
follow-up . This severe progression of regurgitation was
associated with age at operation = 18 months (1 0 of 15 vs . 5
of 28, p :s 0.002) and stenosis progression >20 mm Hg (6 of
9 vs. 9 of 34 P :5 0.05) . Eleven (26%) of43 homografts did not
show progression of regurgitation . Three of the 43 homo-
grafts were observed to have aneurysmal dilation at late
follow-up.
Leaflet abnormalities (Table 2) . By the end of study
period, leaflet abnormalities were visualized by two-
dimensional echocardiograms in 12 (28%) of 43 homografts,
with leaflet prolapse being the most common abnormality
(Table 2). Leaflet abnormalities were detected from < I to
43.5 months (median 15 .2) postoperatively and were associ-
ated with moderate or severe regurgitation in 7 of 12 patients
and with mild regurgitation in 5 . In two of the five, the leaflet
abnormalities were detected only within I month from the
patient's last follow-up . There was no statistically significant
relation between leaflet abnormality and type of homograft
(p 0.56), diagnostic category (p = 0 .26) or age at operation
(p 0.91) .
Prediction of regurgitation. Data were analyzed and a
prediction made of the likelihood that conduits would be free
from severe 3 + to 4 + regurgitation (survival without regur-
gitation). Figure 1 shows that 50% of conduits would have
severe regurgitation by 15 .3 months postoperatively if im-
planted in patients <18 months of age . When homografts
were implanted in patients > 18 months of age, the predicted
homograft survival was 85% without severe regurgitation at
this same follow-up interval .
Conduit Slenosis
Stenosis (Table 3). At the last follow-up, 22 (51%) of
43 homografts were stenotic with a systolic gradient
a25 mm Hg (Table 3) . Five of these 22 (5 [12%] of 43) had a
systolic gradient >50 mm Hg . The sites of stenosis were
distal in 18, distal and proximal in 3 and proximal in 1 .
Diagnostic categories were not related to the final stenosis
status (p = 0 .21) .
Stenosis progression (Table 3) . Nine (21%) of 43 ho-
mografts had stenosis progression >20 mm Hg, including 2
Pt No . Diapns;is
Age at
Operation
(mo)
Leaflet
Abounnalily
AbaormaMy
First Detected
(ma postopl
Slenotic Gradient
at Last Follow-Up
(Tom Hg)
ReguJiation
Grade
at Last
Follow-Up
Hornograft
Type
I PA, VSD 26 .7 Prolapse 0.2 10 1+ Aortic
2a Truncus artedosus 5.2 Prolapse, noncoaptation 7 .4 31 4+ Aortic
2b Truncus arterlosus 17.6 Prolapse 2 .6 65 4+ Pulmonary
3 Critical PS 7.5 Prolapse 4 .5 17 1 + Pulmonary
4 ToF 103.4 Prolapse 4 .7 40 4+ Pulmonary
5 ToF 37.5 Prolapse 24.5 29 2+ Pulmonary
6 ToF 172 .3 Prolapse 37 .3 28 1+ Pulmonary
7 L-TGA, PS 64.0 Prolapse 43 .5 21 3+ Aortic
8 PA. VSD 57.5 Prolapse, noncoaptalion 28,5 20 2+ Pulmonary
9 Infeclive cadocardifis 152 .0 11 1,01apse, nonconplation 32,2 24 4+ Pulmonary
10 QKW wwww's 4.5 fvxcdl open 9,1 48 4+ Aortic
11 Dumus wwribus 1 .0 Dissolved 21 .4 50 4+ Aortic
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Figure 1 . Plot of survival function of regurgitation of 3+ or 4+
severity .
(5%) of 43 with severe progression >40 mm Fig (Table 3) .
Stenosis progression was inversely related to the age at
operation, most noticeable for homografts implanted !518
months (7 of 15 vs. 2 of 28, P :::- 0.005). Stenosis progression
was not related to diagnosis (p = 0.14) or type of homograft
I
® Surgery Age < 18 months
o Surgery Age
a
18 months
*
*
15
a 8
Table 3 . Characteristics of Patients With Homograft Stenosis and Progression of Stenosis and Regurgitation
20
*
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Figure 2. Plot of progression of conduit stenosis as a function of
conduit size .
(p = 0.65). Conduit size was negatively correlated with
progression of stenosis (p < 0 .01) (Fig . 2) .
Prediction of stenosis. A prediction of the likelihood that
conduits would survive without a progression of 20 mm Hg
*Patients with significant stenosis and regurgitation progression (mm Hg) . fIncrease in gradient from initial examination. #Increase in grade of regurgitation
from initial examination . D-TGA = D-transposition of great arteries ; FU = follow-up
; IVS = intact ventricular septum ; Prox = proximal ; other abbreviations
as in Table 2
.
0
Pt No . Diagnosi-
Age at
Operation
(mo)
Time Since
Operation
(mo)
Slenolic
Site
Gradient at Last FU
1mm Hg)
Regurgitation
at Last FU
Homograft
Type
12 ToF 92
57 Distal 26 t+ Aortic
6 ToF
172,3 37.3 Distal 28 I+ Pulmonary
5
TOP 37
.5 24 .5 Distal 29 2+
Pulmonary
13 ToF 217.6 12,4 Distal 30 1+ Pulmonary
2a Truncus arteriosus 5.2 6.2 Distal 31 4+
Aortic
2b* Truncus arteriosus 17 .6 12 .4 Distal 65 (24)t
4+ (2+)# Pulmonary
14 ToF 125 .8 38 .2
Distal
31
2+ Aortic
15
PA, IVS 12.9 60 Distal 32 1+
Aortic
16
D-TGA, PS 42 28
Distal
32
1+ Aortic
17
L-TGA, PS 32 14 Distal 32
3+ Aortic
IS* IATGA, PS 9.7 14 .4 Distal 33 (23)t
1+ Il+)$
Aortic
19 ToF 154 10 Distal 34 1+ Pulmonary
20* ToF 16 27 Distal 38(32)t 2+
Pulmonary
4*
ToF 103.4 45 .6 Prox, distal 40 (30)t
4+ (3+)f
Pulmonary
21*
ToF 58.2 45 Distal 44(28)t I+ (1+)f Aortic
22a
ToF
31 .3 10.5 Distal 60 4+ Pulmonary
22b ToF 43 37
Distal 45 4+
Pulmonary
l0 Truncus arteriosus 4 .5 57
Distal 48
4+ Aortic
11* Tntncus arteriosus 5 58 Distal
50 (40)f
4+ (4+)$ Aortic
23*
Truncus arteriosus 8 26 Prox, distal 60 (4I )t 2+ (2+)t Pulmonary
24*
D.TGA . PS 10 24 Prox
65 (28)t
3+ (3+1# Aortic
25* Ttuncus aneriosus
3 13 Prox, distal 117 (107)t 4+ (3+)# Aortic
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Figure 3 . Plot of survival function of conduit stenosis progression
>20 mm t1g, as measured by Doppler gradient .
stenosis gradient was performed . If conduits were implanted
in patients before age 18 months, 50% would have progres-
sion of 20 mm Hg stenosis by 21 .8 months postoperatively
(Fig. 3). Conduits implanted after this age can be predicted
to have far less progression, with >95% being free from
progression of stenosis by the same time .
Conduit types. Both aortic and pulmonary conduits were
used for repair. No differences in development or progres-
sion of either hornograft valve regurgitation (p = 0 .83) or
stenosis were seen between the two types of conduit at any
age. No preferential use of either type of homograft was
apparent for any particular type of operation or at any
specific age .
Doppler echocardiographic and catheterization gradient
correlation (Fig . 4). Of the 41 patients, 25 had 26 postoper-
ative cardiac catheterizations ; I patient underwent cardiac
catheterization twice 7 months apart for balloon angioplasty
procedures . Three patients are excluded ; in two, echocar-
diographic examination was performed >24 h before cardiac
catheterization and in the third, the homograft could not be
entered by catheter. The data from the remaining 23 cardiac
catheterizations were correlated with Doppler studies . The
time interval between cardiac catheterization and operation
ranged from 3 to 58 months (median 14 .5) . Patient age at the
time of the study ranged from 8 to 248 months (median 55) .
Sixteen (70%) of 23 patients underwent echocardiographic
examination under sedation immediately before cardiac
catheterization. The correlation coefficient between maximal
conduit gradient measured by Doppler study and cardiac
catheterization was 0.86. The regression line followed the
relation : Doppler f1adientf calculated (mm Hg) = 0 .2807 +
0.8015 (Catheterization pressure gradient) .
20
I
I
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Figure 4 . Plot correlating homograft systolic gradients measured by
catheter pullback and continuous wave Doppler echocardiography
(n
= 23, r = 0 .86, y = 0 .2807 + 0.80150 .
Subsequent clinical course of patients . Two (5%) of the 41
patients had a homograft replaced . One patient with severe
tetralogy of Fallot had a homograft replaced because of
significant obstruction and regurgitation 11 .5 months after
the first operation . The other patient, with truncus arterio-
sus, had the second homograft implanted 12 .4 months after
the initial operation because of severe regurgitation and
pulmonary ventricle dysfunction . She died suddenly at home
4 months after the second operation with no significant
illness immediately before death . No autopsy was per-
formed. Four patients underwent a total of six balloon
angioplasty and one pulmonary endovascular stent proce-
dures for distal pulmonary stenosis . Indications for pulmo-
nary artery angioplasty and definition of success have pre-
viously been reported (4) . Successful relief of the stenosis
was observed only in the patient in whom a pulmonary stent
was employed. That particular patient had initial progression
of regurgitation (1+ to 4+) in the presence of stenosis
(gradient 45 mm Hg) with later reduction in regurgitation
from 4+ to 2+ after successful bilateral branch pulmonary
artery stenting. There were no episodes of infective endo-
carditis or thromboembolism throughout the follow-up
period .
	
Discussion
Cryopreserved homografts are advantageous in the re-
construction of ventricular to pulmonary connections be-
cause they are rarely associated with thromboembolic
events or infective endocarditis and have high surgical
versatility . Although work of O'Brien et al
. (5) suggested
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that the viable components of cryopreserved homografts
could enhance their long-term survival over that of other
conduits, previous data (6) revealed the problem of late
tissue degeneration and homograft dysfunction .
ste . In a follow-up study by Kay and
Ross (7) of patients receiving fresh, antibiotic sterilized
aortic homografs, only 13% (three patients) were found to
have a gradient >50 mm Hg requiring conduit replacement
by 10 years. The obstruction in these patients was due to
neointimal hyperplasia in the Dacron extension tube portion
rather than the homograft itself . In the present study,
although a similar proportion of patients (12%) had a gradi-
ent >50 mm Hg, the obstruction occurred much earlier and
in the absence of any Dacron extension, In the study by
Meliones et al . (1) in which cryopreserved homografts were
followed up for a mean of 15 months, only 5% had severe
conduit stenosis. The apparent difference could be due to the
greater proportion of patients in our study who underwent
hom implantation before 24 months of age (39%® vs .
191/16) as well as the longer follow-up period . Age at operation
was related to degree of subsequent stenosis in our study as
well as in previous studies (8,9) . Our finding that stenosis in
homografts occurred most commonly in the distal anasto-
motic sites is consistent with previous reports (1,8,9) . The
preliminary favorable outcome of pulmonary artery stenting
procedure in relieving distal stenosis is encouraging . How-
ever, finding ways to decrease the incidence of distal steno-
sis, especially in infants requiring early pulmonary outflow
reconstruction surgery, would be desirable .
Homograft stenosis has been suggested to be related to
the relative small size of homograft used (t) . The relation
between the age of our patients and the diameter of the
implanted homografts was not much different from that
reported by others (1,9) .
H ste +, . In the study by Kay and
Ross (7) of fresh aortic hom fts, no relation was present
between homograft stenotic gradient and the timing of post .
operative cardiac catheterization . Fontan et al, (10) reported
that only one of seven patients with a fresh aortic homo
had progression f systolic gradients shown at recatheteriza-
tion. In contrast, our present findings document the progres-
sion of systolic gradient because some patients had no
stenotic gradient initially
. The apparent difference between
studies could be accounted for by the longitudinal cohort
study nature of the present study and its universal follow-up
of patients .
H regurgitation regurgitation progression .
Cryopreserved hom s in the pulmonary position have
been found to develop regurgitation in short-term follow-up
studies. The data presented here allow prediction that severe
ho - -
regurgitation is likely if the device is implanted in
patients <18 months of age . In biosynthetic valve studies,
structural degeneration of valves has been shown to occur
with time and may be accelerated in young, active patients,
Perhaps as a result of faster sustained heart rates (11-13) . It
is therefore possible that in the present study involving
JACC Vol. 24 . No . 2
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predominantly younger children, the degree of homograft
tissue degeneration was greater, thus leading to regurgitation
with time. Clarke et al . (14), reporting on cryopreserved
aortic homografts used ii aortic root replacement proce-
dures, also found a significantly higher prevalence of homo-
graft degeneration in patients <3 years of age at operation .
Immunologically mediated host response to the homograft
leading to degeneration was suggested and empiric immuno-
suppressive treatment was attempted in that study. Although
the exact etiology is still not certain, leaflet abnormalities
have been reported as the underlying cause of replacement
of cryopreserved homografts (15) .
Significant regurgitation was shown to be related to the
stenosis across the homograft in previous studies (1) . How-
ever, our study demonstrated in addition an association
between the progression of regurgitation and the concomi-
tant progression of stenosis with time. This Binding is also
reflected by the observation that in one p, tit.nt, the homo-
graft regurgitation initially deteriorated with time in the
presence of stenosis but subsequently lessened after relief of
the distal pulmonary stenosis. Early diagnosis of significant
stenosis was therefore important and relief of distal stenosis
could arrest homograft dysfunction .
Echocar ° phic examination and catheteri tion corre-
lation. Doppler studies of instantaneous maximal gradient in
our study correlated satisfactorily with the peak to peak
gradient measured at cardiac catheterization . In one patient
whose homograft could not be entered because of its abnor-
mal position, the systolic gradient across the homograft thus
could be assessed only by echocardiography . The present
study therefore highlights the validity of echocardiography
in the serial follow-up of these patients .
Echocardiographic and catheterization studies differed in
time and in the degree of sedation and state of consciousness
of the patients, both of which can alter gradient measure-
ment. However, owing to the unusual location of the homo-
grafts, various maneuvers sometimes were required to ob-
tain an adequate echocardiographic window, and studies
were not exactly simultaneous . We believe that measure-
ment of the Doppler gradients within 24 h of or immediately
before cardiac catheterization is a practical alternative .
No attempt was made to correlate the echocardiographic
grading of homograft regurgitation and catheterization findings,
because, in our experience, angiographic grading of pulmonary
insufficiency is insensitive and difficult to quantify .
Conclusions . Malfunction of cryopreserved homografts is
common and dysfunction is progressive in the intermediate
term, and when these conditions are more severe the devices
are implanted in younger children . Serial echocardiographic
examinations detect leaflet abnormalities and reliably assess
homograft dysfunction in these patients . The present find-
ings in this homogeneous patient group with cryopreserved
homografts clearly indicate that use of such homografts in
pulmonary outflow reconstruction does not provide perma-
nent palliation . Optimal methods to improve the viability of
homograft valves, as well as ways to reduce the stenotic
JACC Vol . 24. No . 2
August 1994
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complications, especially of those homografts implanted 4i
early infancy, are thus highly desirable .
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